Sebastian Zimmermann

Objective Response and Prolonged Disease Control of Advanced Adrenocortical Carcinoma with Cabozantinib

Felix Megerle, Max Kurlbaum, Sebastian Zimmermann et al. · The Journal of Clinical Endocrinology & Metabolism · 2020 · 58 citations · Full text

Development and validation of a sensitive liquid chromatography tandem mass spectrometry assay for the simultaneous determination of ten kinase inhibitors in human serum and plasma

Fatemeh Aghai, Sebastian Zimmermann, Max Kurlbaum et al. · Analytical and Bioanalytical Chemistry · 2020 · 37 citations · Full text

Volumetric absorptive microsampling (VAMS) for the quantification of ten kinase inhibitors and determination of their in vitro VAMS-to-plasma ratio

Sebastian Zimmermann, Fatemeh Aghai, Bastian Schilling et al. · Journal of Pharmaceutical and Biomedical Analysis · 2022 · 27 citations

Volumetric Absorptive Microsampling, Vitro Vams-to-plasma Ratio, Pharmaceutical Science +14

Developing a Nationwide Infrastructure for Therapeutic Drug Monitoring of Targeted Oral Anticancer Drugs: The ON-TARGET Study Protocol

Anna M. Mc Laughlin, Eduard Schmulenson, Olga Teplytska et al. · Cancers · 2021 · 17 citations · Full text

Drug Target, Pharmacotherapy, Metronomic Chemotherapy +17

Ruxolitinib exposure in patients with acute and chronic graft versus host disease in routine clinical practice—a prospective single-center trial

Nora Isberner, Sabrina Kraus, Götz Ulrich Grigoleit et al. · Cancer Chemotherapy and Pharmacology · 2021 · 16 citations · Full text